Compare CTXR & GAUZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CTXR | GAUZ |
|---|---|---|
| Founded | 2007 | 2009 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Miscellaneous |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 19.8M | 22.5M |
| IPO Year | N/A | 2024 |
| Metric | CTXR | GAUZ |
|---|---|---|
| Price | $0.92 | $1.12 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 2 |
| Target Price | $6.00 | ★ $11.50 |
| AVG Volume (30 Days) | ★ 1.6M | 437.1K |
| Earning Date | 02-13-2026 | 03-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $96,810,000.00 |
| Revenue This Year | N/A | $22.59 |
| Revenue Next Year | $147.57 | $47.83 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 7.87 |
| 52 Week Low | $0.63 | $0.95 |
| 52 Week High | $4.43 | $13.00 |
| Indicator | CTXR | GAUZ |
|---|---|---|
| Relative Strength Index (RSI) | 43.39 | 36.53 |
| Support Level | $0.76 | $1.17 |
| Resistance Level | $0.99 | $1.39 |
| Average True Range (ATR) | 0.11 | 0.21 |
| MACD | 0.01 | 0.11 |
| Stochastic Oscillator | 50.00 | 24.92 |
Citius Pharmaceuticals Inc is a biopharmaceutical company with a focus on anti-infectives in adjunct cancer care, prescription products, and stem cell therapy. The company is currently advancing four proprietary product candidates namely, LYMPHIR for the treatment of patients with persistent or recurrent cutaneous T-cell lymphoma. Mino-Lok, which is an antibiotic lock solution used to treat patients with catheter-related bloodstream infections, Mino-Wrap, a liquifying gel-based wrap for reduction of tissue expander infections following breast reconstructive surgeries, Halo-Lido, a topical formulation that is intended to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids, and others.
Gauzy Ltd is a fully integrated light and vision control company. Its products include suspended particle device and liquid crystal materials for smart glass applications and AI-powered driver assistance systems, or ADAS, solutions including camera monitoring systems. The company's operating segments are Architecture, Automotive, Safety tech, and Aeronautics. Maximum revenue is generated from its Safety tech segment, which focuses on sales of driver assistance systems for buses, coaches, recreational vehicles, and specific vehicles, such as camera and motion sensor systems, smart mirrors, and safety doors. Geographically, it derives maximum revenue from other European countries (excluding France), followed by the United States, France, Asia, Israel, and other regions.